| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 07/24/2007 | US7247756 1,4-disubstituted benzenes as insecticides |
| 07/24/2007 | US7247748 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and reverse cholesterol transport |
| 07/24/2007 | US7247744 Reacting a probucol derivatives with succinic, glutaric, adipic, suberic, sebacic, azelaic, phthalic or maleic anhydride in the presence of a prophosphatrane to form a water soluble mono- or bis(carboxyalkanoyl ester) |
| 07/19/2007 | WO2007080140A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators |
| 07/19/2007 | WO2007003295A3 Method for producing 3-arylmethylthio- and 3-heteroarylmethylthio-4,5-dihydro-isoxazoline derivatives |
| 07/19/2007 | US20070167499 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 07/19/2007 | CA2635719A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators |
| 07/18/2007 | EP1807405A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 07/18/2007 | EP1807393A1 Diarylsulfones as 5-ht2a antagonists |
| 07/18/2007 | CN101001833A Organic compounds |
| 07/17/2007 | US7244861 Insulin sensitizer; antidiabetic agents; antiproliferative agents; antiinflammatory agents |
| 07/17/2007 | US7244763 Compounds that modulate PPAR activity and methods of preparation |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/12/2007 | WO2007079162A1 Isoxazolines for controlling invertebrate pests |
| 07/12/2007 | US20070161800 Nitriting; industrial scale; crop protection |
| 07/12/2007 | US20070161690 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161026 Regents labeled with energy transfer dyes |
| 07/12/2007 | CA2632694A1 Isoxazolines for controlling invertebrate pests |
| 07/11/2007 | EP1805129A1 (biphenyl) carboxylic acids and derivatives thereof |
| 07/11/2007 | CN1997628A Thio-substituted biaryl-methanesulfinyl derivatives |
| 07/10/2007 | US7241786 Compounds inhibit A beta -peptide production; may be used for treatment of Alzheimer's disease and other neurological disorders in mammals, including humans |
| 07/05/2007 | US20070155839 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene) methyl]benzoic acid; selective estrogen receptor modulation; SERMS |
| 07/05/2007 | US20070155795 Muscarinic agonists |
| 07/05/2007 | US20070155704 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | US20070154927 Energy transfer dyes with enhanced fluorescence |
| 07/05/2007 | US20070154924 An acceptor fluorophore efficiently absorbs energy emission of a linked donor xanthene fluorophore labelling a oligonucleotide primer, reagent for sequencing nucleic acids, DNA sequencing |
| 07/04/2007 | EP1802612A1 Novel b1 bradykinin receptor antagonists |
| 07/04/2007 | EP1802566A1 Hexafluoroisopropanol substituted ether derivatives |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1324006C Beta-amino acid nitrile derivs. |
| 07/04/2007 | CN1324001C Novel thyroid receptor ligands |
| 07/03/2007 | US7238713 Muscarinic agonists |
| 07/03/2007 | US7238689 Crop and weed selectivity |
| 06/28/2007 | WO2007073518A2 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 06/28/2007 | WO2007072164A2 Estrogen modulators |
| 06/28/2007 | WO2007071900A1 Novel herbicides |
| 06/28/2007 | WO2007071311A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/28/2007 | WO2007005531A3 Alkenyldiarylmethanes, fused analogs and syntheses thereof |
| 06/28/2007 | US20070149786 Polycyclic ketone compound and process for producing the same |
| 06/28/2007 | US20070149615 Ketone compounds and compositions for cholesterol management and related uses |
| 06/28/2007 | US20070149531 Antiviral agents |
| 06/28/2007 | US20070149530 Antiviral agents |
| 06/28/2007 | US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 06/28/2007 | CA2669503A1 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 06/28/2007 | CA2631145A1 Novel herbicides |
| 06/28/2007 | CA2629065A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/28/2007 | CA2628596A1 Estrogen modulators |
| 06/27/2007 | EP1801098A1 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors |
| 06/27/2007 | EP1799658A2 Modulators of crth2 rezeptor activity for the treatment of prostaglandin d2 mediated diseases |
| 06/27/2007 | EP1799657A1 Isoxazoline derivatives and their use as herbicides |
| 06/27/2007 | EP1799636A2 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1077955B1 Method for producing isoxazoline-3-yl-acyl benzene |
| 06/26/2007 | US7235664 Potassium channel modulators; antiarrhythmia agents |
| 06/26/2007 | US7235575 Guanidine mimics as factor Xa inhibitors |
| 06/21/2007 | WO2007069773A1 A pharmaceutical composition comprising an amide derivative |
| 06/21/2007 | WO2007068330A1 2-ADAMANTYLUREA DERIVATIVES AS SELECTIVE 11β-HSD1 INHIBITORS |
| 06/21/2007 | US20070142644 directly chlorinating the crystalline form of anhydrous 1,2-benzisoxazole-3-methanesulfonic acid to form 1,2-benzisoxazole-3-methanesulfonyl chloride and a subsequent novel amidation procedure |
| 06/21/2007 | US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors |
| 06/21/2007 | US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/21/2007 | US20070142381 Calcium receptor modulating agents |
| 06/21/2007 | US20070142333 Cycloalkyl inhibitors of potassium channel function |
| 06/21/2007 | US20070142329 2-Chloro-N-[2-(2-chloro-phenyl)-ethyl]-5-(6-oxo-1,6-dihydro-pyrazin-3-yl)benzamide, for example; useful in the treatment of IL-1 mediated disorders, including inflammatory diseases such as osteoarthritis and rheumatoid arthritis, allergies, asthma, COPD, cancer |
| 06/21/2007 | US20070142229 Agriculture |
| 06/21/2007 | CA2633186A1 2-adamantylurea derivatives as selective 11.beta.-hsd1 inhibitors |
| 06/20/2007 | EP1796665A2 Compounds for the treatment of dyslipidemia and other lipid disorders |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | CN1984894A Compounds and compositions as PPAR modulators |
| 06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
| 06/19/2007 | US7232792 3-heterocyclyl-substituted benzoyl derivatives |
| 06/14/2007 | WO2007067817A1 Abca1 elevating compounds |
| 06/14/2007 | WO2007067710A1 Certain chemical entities, compositions, and methods for modulating trpv1 |
| 06/14/2007 | WO2007030582A3 Acyclic ikur inhibitors |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135500 Propionamide compounds as antiinflammatory agents |
| 06/14/2007 | US20070135496 Substituted benzylaminoalkylene heterocycles |
| 06/13/2007 | CN1980892A Dpp-IV inhibitors |
| 06/12/2007 | US7230099 Heterocyclic inhibitors of MEK and methods of use thereof |
| 06/12/2007 | US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer |
| 06/12/2007 | US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | CA2354023C Phenylglycine derivatives |
| 06/07/2007 | WO2007063950A1 Long-wave fluorescent substance for diagnosis or treatment of conformation disease and use thereof |
| 06/07/2007 | US20070129369 Heteroaryl substituted cyclohexyl-1,4-diamine compounds |
| 06/06/2007 | EP1791807A1 Therapeutic diphenyl ether ligands |
| 06/06/2007 | EP1286991B1 Cyclopropyl-anellated 3-(4,5-dihydroisoxazol-3-yl)-substitued benzoylpyrazoles |
| 06/06/2007 | CN1976911A Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives |
| 06/06/2007 | CN1976892A Substituted enaminones, their derivatives and uses thereof |
| 06/05/2007 | US7226940 Such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 05/31/2007 | WO2007060026A1 Urea derivatives useful as calcium receptor modulators |
| 05/31/2007 | WO2007024836A3 Preparation of tetrahydro-1,8-dioxa-4a-aza-naphthalenes and their use in coating applications |
| 05/31/2007 | CA2630860A1 Urea derivatives useful as calcium receptor modulators |
| 05/30/2007 | EP1789401A1 Isoxazoline derivatives and their use as herbicides |
| 05/30/2007 | EP1003730B1 2-benzoyl-cyclohexane-1,3-diones |
| 05/30/2007 | CN1972914A Non-imidazole heterocyclic compounds as histamine H3-receptor ligands |
| 05/30/2007 | CN1318027C GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 05/29/2007 | US7223868 Heteroaromatic glucokinase activators |
| 05/29/2007 | US7223794 For example, 2-{[(1S)-2-amino-1-phenylethyl]oxy}-4-chloro-5-fluorobenzonitrile; use in treatment or prophylaxis of inflammatory diseases and CNS diseases |